Are Genetics Tests Being Rushed to Market?
Can a blood test really detect cancer before symptoms appear? Pathway Genomics CEO Jim Plante sits down with CBS News correspondent Jim Axelrod to discuss.
JIM AXELROD: Can you tell me about the studies you've done?
JIM PLANTE: Before we launched the test, we had a clinical study of more than 100...
AXELROD: Is 100 enough?
PLANTE: Well, it depends on what you're looking for, right? I mean, you can make an argument that there's never enough data, right? But as you get more information, then you can say more things.
...
Our test has been validated under the current regulatory requirements.
